After Delays, Nucleonics to Move Hep B Drug To Clinic in '07; Firm Unveils New Rx Goals - RNAi

After Delays, Nucleonics to Move Hep B Drug To Clinic in '07; Firm Unveils New Rx Goals

After Delays, Nucleonics to Move Hep B Drug To Clinic in '07; Firm Unveils New Rx Goals
30 Nov 2006
RNAi News
After struggling with optimization of its hepatitis B drug candidate, Nucleonics is now on track to begin phase I testing in the first quarter of 2007. The company has also initiated preclinical programs in cancer and influenza.
Paid subscription is required to view article.